Specialist advisory committees

Last updated

26 June 2024 | CTAC agenda added for July meeting

12 June 2024 | Updated Cardiovascular and Tender Clinical Advisory Committee memberships.

13 June 2024 | Links to clinical advice received from the Endocrinology and Reproductive and Sexual Health committees on oestradiol patches and alternatives. (Advice first published in July 2023)     

17 June 2024 | Membership of Anti-infectives and Rare Disorders committees updated.

About specialist advisory committees

Pharmac’s specialist advisory committees provide Pharmac with objective specialist knowledge and expertise within specific clinical areas, such as diabetes, cancer, and mental health. They meet as needed to discuss issues within their clinical areas.

The specialist advisory committees have a different, but complementary, role from PTAC. Their expertise and perspectives can differ from PTAC. 

PTAC and specialist advisory committees may make recommendations to Pharmac that differ from each other when looking at the same evidence. Pharmac considers the recommendations provided by all our clinical advisory committees when assessing applications.

Members of specialist advisory committees are appointed by the Pharmac board. They are not Pharmac employees, but we do pay for their travel and time. 

Note: before November 2021, specialist advisory committees were called Subcommittees.

Read the specialist advisory committee terms of reference